Bengaluru, Jan. 18 -- Immuneel Therapeutics Private Limited (Immuneel) on Monday announced setting up of the country's first Integrated Cell Therapy Development and Manufacturing Facility here in Narayana Hrudayalaya Health City. The 12,000-sq.ft. integrated facility includes a state-of-the-art laboratory, cGMP-compliant manufacturing suites which will bring breakthrough cell and gene therapies to millions of patients in India. The facility is compliant with Indian Gene Therapy Product (GTP) guidelines released in 2019 and Global cGMP guidelines for advanced therapy medicinal products (ATMP) published by EMA and USFDA with a focus on manufacturing and quality systems specific to cell therapies, according to a press release here on Monday. D...